{"id":30505,"date":"2025-01-27T10:19:02","date_gmt":"2025-01-27T09:19:02","guid":{"rendered":"https:\/\/ggba.swiss\/geneva-medtech-ebamed-completes-financing-round-with-eur-16-million\/"},"modified":"2025-01-27T10:24:45","modified_gmt":"2025-01-27T09:24:45","slug":"la-medtech-genevoise-ebamed-boucle-son-tour-de-table-avec-eur-16-millions","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/la-medtech-genevoise-ebamed-boucle-son-tour-de-table-avec-eur-16-millions\/","title":{"rendered":"La medtech genevoise EBAMed boucle son tour de table avec EUR 16 millions"},"content":{"rendered":"\n<p>Fond\u00e9e \u00e0 Gen\u00e8ve, <a href=\"https:\/\/eba-med.com\/\">EBAMed<\/a> est sp\u00e9cialis\u00e9e dans les solutions innovantes pour le traitement des arythmies cardiaques \u00e0 l&rsquo;aide de la technologie avanc\u00e9e de la protonth\u00e9rapie. Son produit phare, le syst\u00e8me CardioKit, offre une alternative non invasive aux traitements traditionnels en combinant une radioth\u00e9rapie pr\u00e9cise avec le suivi des mouvements cardiaques. Cette approche r\u00e9pond \u00e0 un besoin croissant de solutions efficaces et conviviales pour g\u00e9rer les tachycardies ventriculaires (TV), une maladie potentiellement mortelle qui touche des millions de personnes dans le monde.<\/p>\n\n\n\n<p>Le dernier financement a \u00e9t\u00e9 accord\u00e9 dans le cadre du Piano Nazionale di Ripresa e Resilienza (PNRR) de l&rsquo;Italie et de l&rsquo;<a href=\"https:\/\/next-generation-eu.europa.eu\/index_en\">initiative Next Generation EU<\/a> de l&rsquo;<a href=\"https:\/\/next-generation-eu.europa.eu\/index_en\">Union Europ\u00e9enne<\/a>. \u00ab Notre plus grande gratitude va \u00e0 <a href=\"https:\/\/www.cdpventurecapital.it\/cdp-venture-capital\/en\/home.page\">CDP Venture Capital<\/a> et \u00e0 l&rsquo;Union Europ\u00e9enne pour leur confiance en notre vision et leur soutien vital \u00bb, a d\u00e9clar\u00e9 la CEO Marina Izzo dans le communiqu\u00e9 de l&rsquo;entreprise. \u00ab Cet investissement nous propulse vers l&rsquo;avant dans notre mission de construire des solutions de sant\u00e9 innovantes qui am\u00e9liorent la sant\u00e9 des gens et renforcent le syst\u00e8me de sant\u00e9. \u00bb<\/p>\n\n\n\n<p>Le nouveau financement fait suite aux EUR 14,35 millions lev\u00e9s en juin 2023 aupr\u00e8s d&rsquo;un consortium dirig\u00e9 par <a href=\"http:\/\/www.panakes.it\/\">Panak\u00e8s Partners<\/a>, aux c\u00f4t\u00e9s du <a href=\"https:\/\/eic.ec.europa.eu\/investment-opportunities_en\">Conseil europ\u00e9en de l&rsquo;innovation (EIC<\/a>), <a href=\"https:\/\/lakegenevaventures.com\/\">EFI Lake Geneva Ventures<\/a>, de <a href=\"https:\/\/www.liftt.com\/en\/liftt-venture-capital-en\/\">LIFTT Venture Capital Italia<\/a>, d&rsquo;<a href=\"https:\/\/www.occident.group\/\">OCCIDENT<\/a>, et d&rsquo;autres investisseurs, y compris <a href=\"https:\/\/www.mayoclinic.org\/\">Mayo Clinic<\/a>.<\/p>\n\n\n\n<p>Le financement de la s\u00e9rie A \u00e9tant maintenant termin\u00e9, EBAMed se concentre sur l&rsquo;avancement du syst\u00e8me CardioKit vers les derni\u00e8res \u00e9tapes des essais cliniques, marquant ainsi une \u00e9tape cruciale vers le d\u00e9ploiement commercial.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Une avanc\u00e9e significative dans les traitements non invasifs<\/h4>\n\n\n\n<p>Les arythmies cardiaques, qui touchent environ 50 millions de personnes dans le monde, devraient augmenter consid\u00e9rablement en raison du vieillissement de la population. Le syst\u00e8me CardioKit d&rsquo;EBAMed r\u00e9pond \u00e0 ce d\u00e9fi par une approche non invasive du traitement des tachycardies ventriculaires (TV), une affection potentiellement mortelle.<\/p>\n\n\n\n<p>Le syst\u00e8me CardioKit int\u00e8gre une technologie avanc\u00e9e de surveillance des mouvements et de d\u00e9clenchement pour am\u00e9liorer la pr\u00e9cision de la radioth\u00e9rapie par protons, en minimisant l&rsquo;exposition aux rayonnements des tissus cardiaques sains. Cette solution innovante constitue une alternative convaincante \u00e0 la pharmacoth\u00e9rapie traditionnelle ou \u00e0 l&rsquo;ablation par cath\u00e9ter, offrant de meilleurs r\u00e9sultats aux patients souffrant d&rsquo;arythmies complexes.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>EBAMed a obtenu un financement suppl\u00e9mentaire de EUR 1,6 million, ce qui porte le total des fonds lev\u00e9s \u00e0 EUR 16 millions. Ce nouveau financement, apport\u00e9 par CDP Venture Capital et l&rsquo;Union Europ\u00e9enne, soutient le d\u00e9veloppement du syst\u00e8me r\u00e9volutionnaire CardioKit d&rsquo;EBAMed pour le traitement non invasif des arythmies cardiaques \u00e0 l&rsquo;aide de la protonth\u00e9rapie.<\/p>\n","protected":false},"author":6,"featured_media":30502,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1148,1188,1181,1163,1185],"class_list":["post-30505","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-financing-fr-2","tag-healthcare-fr-2","tag-medical-devices-fr","tag-medtech-fr-2","tag-radiotherapy-fr-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>EBAMed boucle son tour de table avec EUR 16 millions | GGBa<\/title>\n<meta name=\"description\" content=\"EBAMed a obtenu un financement suppl\u00e9mentaire de EUR 1,6 million, ce qui porte le total des fonds lev\u00e9s \u00e0 EUR 16 millions.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/la-medtech-genevoise-ebamed-boucle-son-tour-de-table-avec-eur-16-millions\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EBAMed boucle son tour de table avec EUR 16 millions | GGBa\" \/>\n<meta property=\"og:description\" content=\"EBAMed a obtenu un financement suppl\u00e9mentaire de EUR 1,6 million, ce qui porte le total des fonds lev\u00e9s \u00e0 EUR 16 millions.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/la-medtech-genevoise-ebamed-boucle-son-tour-de-table-avec-eur-16-millions\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-27T09:19:02+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-27T09:24:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/EBAMed-Heart-Arrhytmia-scaled.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/la-medtech-genevoise-ebamed-boucle-son-tour-de-table-avec-eur-16-millions\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/la-medtech-genevoise-ebamed-boucle-son-tour-de-table-avec-eur-16-millions\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"La medtech genevoise EBAMed boucle son tour de table avec EUR 16 millions\",\"datePublished\":\"2025-01-27T09:19:02+00:00\",\"dateModified\":\"2025-01-27T09:24:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/la-medtech-genevoise-ebamed-boucle-son-tour-de-table-avec-eur-16-millions\/\"},\"wordCount\":418,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/la-medtech-genevoise-ebamed-boucle-son-tour-de-table-avec-eur-16-millions\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/EBAMed-Heart-Arrhytmia-scaled.jpeg\",\"keywords\":[\"Financing\",\"Healthcare\",\"Medical Devices\",\"Medtech\",\"Radiotherapy\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/fr\/la-medtech-genevoise-ebamed-boucle-son-tour-de-table-avec-eur-16-millions\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/la-medtech-genevoise-ebamed-boucle-son-tour-de-table-avec-eur-16-millions\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/la-medtech-genevoise-ebamed-boucle-son-tour-de-table-avec-eur-16-millions\/\",\"name\":\"EBAMed boucle son tour de table avec EUR 16 millions | GGBa\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/la-medtech-genevoise-ebamed-boucle-son-tour-de-table-avec-eur-16-millions\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/la-medtech-genevoise-ebamed-boucle-son-tour-de-table-avec-eur-16-millions\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/EBAMed-Heart-Arrhytmia-scaled.jpeg\",\"datePublished\":\"2025-01-27T09:19:02+00:00\",\"dateModified\":\"2025-01-27T09:24:45+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"EBAMed a obtenu un financement suppl\u00e9mentaire de EUR 1,6 million, ce qui porte le total des fonds lev\u00e9s \u00e0 EUR 16 millions.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/la-medtech-genevoise-ebamed-boucle-son-tour-de-table-avec-eur-16-millions\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/la-medtech-genevoise-ebamed-boucle-son-tour-de-table-avec-eur-16-millions\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/la-medtech-genevoise-ebamed-boucle-son-tour-de-table-avec-eur-16-millions\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/EBAMed-Heart-Arrhytmia-scaled.jpeg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/EBAMed-Heart-Arrhytmia-scaled.jpeg\",\"width\":2560,\"height\":1707,\"caption\":\"EBAMed d\u00e9veloppe des solutions innovantes pour le traitement non invasif et indolore des arythmies cardiaques par radioth\u00e9rapie (ablation par faisceau externe).\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/la-medtech-genevoise-ebamed-boucle-son-tour-de-table-avec-eur-16-millions\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"La medtech genevoise EBAMed boucle son tour de table avec EUR 16 millions\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EBAMed boucle son tour de table avec EUR 16 millions | GGBa","description":"EBAMed a obtenu un financement suppl\u00e9mentaire de EUR 1,6 million, ce qui porte le total des fonds lev\u00e9s \u00e0 EUR 16 millions.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/la-medtech-genevoise-ebamed-boucle-son-tour-de-table-avec-eur-16-millions\/","og_locale":"fr_FR","og_type":"article","og_title":"EBAMed boucle son tour de table avec EUR 16 millions | GGBa","og_description":"EBAMed a obtenu un financement suppl\u00e9mentaire de EUR 1,6 million, ce qui porte le total des fonds lev\u00e9s \u00e0 EUR 16 millions.","og_url":"https:\/\/ggba.swiss\/fr\/la-medtech-genevoise-ebamed-boucle-son-tour-de-table-avec-eur-16-millions\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2025-01-27T09:19:02+00:00","article_modified_time":"2025-01-27T09:24:45+00:00","og_image":[{"width":2560,"height":1707,"url":"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/EBAMed-Heart-Arrhytmia-scaled.jpeg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Pierre-Yves Oehrli","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/la-medtech-genevoise-ebamed-boucle-son-tour-de-table-avec-eur-16-millions\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/la-medtech-genevoise-ebamed-boucle-son-tour-de-table-avec-eur-16-millions\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"La medtech genevoise EBAMed boucle son tour de table avec EUR 16 millions","datePublished":"2025-01-27T09:19:02+00:00","dateModified":"2025-01-27T09:24:45+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/la-medtech-genevoise-ebamed-boucle-son-tour-de-table-avec-eur-16-millions\/"},"wordCount":418,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/fr\/la-medtech-genevoise-ebamed-boucle-son-tour-de-table-avec-eur-16-millions\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/EBAMed-Heart-Arrhytmia-scaled.jpeg","keywords":["Financing","Healthcare","Medical Devices","Medtech","Radiotherapy"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/fr\/la-medtech-genevoise-ebamed-boucle-son-tour-de-table-avec-eur-16-millions\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/la-medtech-genevoise-ebamed-boucle-son-tour-de-table-avec-eur-16-millions\/","url":"https:\/\/ggba.swiss\/fr\/la-medtech-genevoise-ebamed-boucle-son-tour-de-table-avec-eur-16-millions\/","name":"EBAMed boucle son tour de table avec EUR 16 millions | GGBa","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/la-medtech-genevoise-ebamed-boucle-son-tour-de-table-avec-eur-16-millions\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/la-medtech-genevoise-ebamed-boucle-son-tour-de-table-avec-eur-16-millions\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/EBAMed-Heart-Arrhytmia-scaled.jpeg","datePublished":"2025-01-27T09:19:02+00:00","dateModified":"2025-01-27T09:24:45+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"EBAMed a obtenu un financement suppl\u00e9mentaire de EUR 1,6 million, ce qui porte le total des fonds lev\u00e9s \u00e0 EUR 16 millions.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/la-medtech-genevoise-ebamed-boucle-son-tour-de-table-avec-eur-16-millions\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/la-medtech-genevoise-ebamed-boucle-son-tour-de-table-avec-eur-16-millions\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/la-medtech-genevoise-ebamed-boucle-son-tour-de-table-avec-eur-16-millions\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/EBAMed-Heart-Arrhytmia-scaled.jpeg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/EBAMed-Heart-Arrhytmia-scaled.jpeg","width":2560,"height":1707,"caption":"EBAMed d\u00e9veloppe des solutions innovantes pour le traitement non invasif et indolore des arythmies cardiaques par radioth\u00e9rapie (ablation par faisceau externe)."},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/la-medtech-genevoise-ebamed-boucle-son-tour-de-table-avec-eur-16-millions\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"La medtech genevoise EBAMed boucle son tour de table avec EUR 16 millions"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/30505","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=30505"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/30505\/revisions"}],"predecessor-version":[{"id":30507,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/30505\/revisions\/30507"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/30502"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=30505"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=30505"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=30505"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}